GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Interest Expense

Renhe Pharmacy Co (SZSE:000650) Interest Expense : ¥-0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Renhe Pharmacy Co's interest expense for the three months ended in Mar. 2024 was ¥ -0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Renhe Pharmacy Co's Operating Income for the three months ended in Mar. 2024 was ¥ 252 Mil. Renhe Pharmacy Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -0 Mil. Renhe Pharmacy Co's Interest Coverage for the quarter that ended in Mar. 2024 was 5,253.44. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Renhe Pharmacy Co Interest Expense Historical Data

The historical data trend for Renhe Pharmacy Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Interest Expense Chart

Renhe Pharmacy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -1.42 -0.98 -0.43 -0.35

Renhe Pharmacy Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.09 -0.08 -0.06 -0.05

Renhe Pharmacy Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renhe Pharmacy Co  (SZSE:000650) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Renhe Pharmacy Co's Interest Expense for the three months ended in Mar. 2024 was ¥-0 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥252 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥0 Mil.

Renhe Pharmacy Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*252.165/-0.048
=5,253.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Renhe Pharmacy Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Renhe Pharmacy Co (SZSE:000650) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Interest Expense
Comparable Companies
SZSE:002424 SZSE:002581 SHSE:605507 SHSE:600216 SHSE:688321 SZSE:300363 SHSE:600195 SZSE:002038 SHSE:600812 SZSE:000756 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038
Website
http://www.renheyaoye.com
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.

Renhe Pharmacy Co (SZSE:000650) Headlines

No Headlines